|Title:||Pseudouridimycin : the first nucleoside analogue that selectively inhibits bacterial RNA polymerase|
|Authors :||Chellat, Mathieu F.|
|Published in :||Angewandte Chemie : international Edition|
|Publisher / Ed. Institution :||Wiley|
|License (according to publishing contract) :||Licence according to publishing contract|
|Type of review:||Peer review (Publication)|
|Subjects :||RNA polymerase; Antibiotics; Medicinal chemistry; Natural products; Nucleoside analogues|
|Subject (DDC) :||615: Pharmacology and therapeutics|
|Abstract:||Seek, and ye shall find: After years of focusing research on synthetic antibiotics out of fear that all the useful natural ones had already been found, a novel antibacterial compound has been discovered through conventional microbial extract screening. The broad-spectrum nucleoside-analogue inhibitor pseudouridimycin is selective for bacterial RNA polymerase and elicits very low resistance rates.|
|Departement:||Life Sciences und Facility Management|
|Publication type:||Article in scientific Journal|
|Appears in Collections:||Publikationen Life Sciences und Facility Management|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.